SCHEMBL6838542

SCHEMBL6838542

FC(F)(F)c1nc2cc(Cl)ccc2c2c1nc(-c1ccco1)n2CCC1CNCCO1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 2/20 0.33
PIK3CA P42336 2/20 0.33
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC6A2 P23975 10/20 0.31
SLC6A4 P31645 9/20 0.31
SLC6A3 Q01959 6/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HBB P68871 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838548 0.91 SLC6A2 (0.32) ALDH1A1KDM4EHPGDMAPTNPSR1
SCHEMBL6838620 0.91 SLC6A2 (0.38) ALDH1A1KDM4EHPGDSLC6A2SLC6A4
SCHEMBL6837812 0.89 EGFR (0.39) KDM4ELMNAHTTSLC6A2SLC6A4
SCHEMBL6837741 0.87 NPY1R (0.37) PIK3R1PIK3CAALDH1A1KDM4EHPGD
SCHEMBL6838695 0.87 SLC6A2 (0.32) SLC6A2SLC6A4SLC6A3EPHA2
SCHEMBL6837670 0.85 HTR6 (0.34) ALDH1A1KDM4EHPGDHTTNPSR1
SCHEMBL6838090 0.84 EPHA2 (0.34) SLC6A2SLC6A4EPHA2MKNK1
SCHEMBL6837757 0.84 SSTR4 (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3SMN1; SMN2
SCHEMBL6838194 0.83 EPHA2 (0.32) EPHA2MKNK1
SCHEMBL6838072 0.83 HRH1 (0.35) PIK3R1PIK3CAALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 PIK3R1 2735/4885PIK3CA 3897/4885ALDH1A1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.